Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
4-(1R,3AS,4R,8AS,8BR)-[1-difluoromethyl-2-(4-fluorobenzyl)-3-oxodecahydropyrrolo[3,4-a]pyrrolizin-4-yl]benzamidine
- Development stage
- Unknown
- Lead developer
- Derm-Biome Pharmaceuticals
- Modality
- Small Molecules
01
Overview
This compound is a synthetic small molecule with the chemical formula C24H27F3N4O and a molecular weight of approximately 444.5 g/mol. It features a polycyclic structure containing both benzamidine and pyrrolizine motifs as well as difluoro and fluorobenzyl substituents. The drug is listed in chemical databases such as PubChem (CID: 46937090), DrugBank (DB07741), ChemSpider (ID: 25060827), and structural biology resources under the code F25. There are no approved medical indications or clinical trials reported for this molecule; it is classified as an experimental compound with no known mechanism of action or therapeutic use at this time[1][2][5].
- Other names
- (1S,3aS,4R,8aS,8bR)-4-[4-(diaminomethyl)phenyl]-1-(difluoromethyl)-2-(4-fluorobenzyl)octahydropyrrolo[3,4-a]pyrrolizin-3(2H)-one(1S,3aS,4R,8aS,8bR)-4-[4-(diaminomethyl)phenyl]-1-(difluoromethyl)-2-[(4-fluorophenyl)methyl]-decahydropyrrolo[3,4-a]pyrrolizin-3-one46937090 (PubChem CID)
Beyond the preview
Go deeper on 4-(1R,3AS,4R,8AS,8BR)-[1-difluoromethyl-2-(4-fluorobenzyl)-3-oxodecahydropyrrolo[3,4-a]pyrrolizin-4-yl]benzamidine.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on 4-(1R,3AS,4R,8AS,8BR)-[1-difluoromethyl-2-(4-fluorobenzyl)-3-oxodecahydropyrrolo[3,4-a]pyrrolizin-4-yl]benzamidine.